Table 3.
Intensive care unit (ICU) data after inverse probability of treatment weighting.
| Intensive Care Unit Data | HA (n = 41) | Control (n = 200) | Stddiff | p |
|---|---|---|---|---|
| Administration of | ||||
| ● Epinephrine | 23 (57.1%) | 89 (44.7%) | −0.250 | 0.365 * |
| ● Dobutamine | 1 (3.5%) | 7 (3.6%) | 0.006 | 0.612 * |
| ● Milrinone | 17 (42.2%) | 34 (17.2%) | −0.567 | 0.046 * |
| ● Nitroglycerine | 2 (4.2%) | 29 (14.4%) | 0.357 | 0.057 |
| ● Norepinephrine | 36 (88.4%) | 106 (52.8%) | −0.848 | 0.001 * |
| ● RBC | 27 (65.2%) | 61 (30.6%) | −0.738 | 0.003 |
| ● Tranexamic acid | 1 (1.9%) | 8 (3.9%) | 0.122 | 0.497 |
| ● Haemate | 3 (7.6%) | 7 (3.3%) | −0.190 | 0.241 |
| ● FFP | 24 (58.3%) | 49 (24.6%) | −0.730 | 0.075 * |
| ● Fibrinogen | 13 (31.2%) | 29 (14.6%) | −0.405 | 0.194 |
| ● PCC | 4 (8.6%) | 25 (12.7%) | 0.132 | 0.489 |
| ● Platelets | 15 (36.7%) | 20 (9.8%) | −0.673 | 0.013 |
| Intubation >72 h | 9 (20.8%) | 20 (9.9%) | −0.305 | 0.406 |
| Drainage >800 mL within 12 h | 18 (43.7%) | 48 (23.8%) | −0.430 | 0.128 |
| Length of ICU stay, days | 5.1 (3.8 to 6.8) | 3.2 (2.7 to 3.8) | 0.546 | 0.230 |
| RRT | 3 (6.4%) | 13 (6.5%) | 0.007 | 0.970 |
| Reoperation for bleeding | 14 (34.0%) | 15 (7.7%) | −0.685 | 0.011 |
| Reoperation later than 24 h | 10 (23.6%) | 10 (4.8%) | −0.559 | 0.062 |
HA: hemoadsorption group; stddiff: standardized difference; RBC: red blood cell concentrates; FFP: fresh frozen plasma; PCC: prothrombin complex concentrate; RRT: renal replacement therapy, * adjusted for impact of time.